0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pregabalin API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8U10618
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pregabalin API Market Research Report 2022
BUY CHAPTERS

Global Pregabalin API Market Research Report 2025

Code: QYRE-Auto-8U10618
Report
March 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pregabalin API Market

The global market for Pregabalin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pregabalin API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pregabalin API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pregabalin API include SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila, Sunshine Pharmaceutical, Hanmi Fine Chemical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pregabalin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pregabalin API.
The Pregabalin API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pregabalin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pregabalin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pregabalin API Market Report

Report Metric Details
Report Name Pregabalin API Market
by Type
  • Purity ≥99%
  • Purity ≥99.5%
by Application
Production by Region
  • North America
  • Europe
  • China
  • India
  • South Korea
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila, Sunshine Pharmaceutical, Hanmi Fine Chemical, Rivocean Jiangsu Pharmaceutical, Hubei Vanz Pharm, Menovo, Saintsun, SyncoZymes, Taian Aidi Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pregabalin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pregabalin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pregabalin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pregabalin API Market report?

Ans: The main players in the Pregabalin API Market are SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila, Sunshine Pharmaceutical, Hanmi Fine Chemical, Rivocean Jiangsu Pharmaceutical, Hubei Vanz Pharm, Menovo, Saintsun, SyncoZymes, Taian Aidi Biotechnology

What are the Application segmentation covered in the Pregabalin API Market report?

Ans: The Applications covered in the Pregabalin API Market report are Tablet, Capsule, Oral Liquid

What are the Type segmentation covered in the Pregabalin API Market report?

Ans: The Types covered in the Pregabalin API Market report are Purity ≥99%, Purity ≥99.5%

Recommended Reports

Related API Markets

Analgesic & Anti-inflammatory APIs

Drug Development & Adjacent

Market trends :

Topic Trends
Global the pregabalin api market is experiencing increased demand driven by rising generic drug production and expanding pharmaceutical manufacturing capabilities in asia-pacific and north america.
Type Purity ≥99% - manufacturers are focusing on producing pregabalin api with purity ≥99% to meet stringent regulatory standards and support high-quality generic drug formulations.
Purity ≥99.5% - the market is witnessing a shift towards pregabalin api with purity ≥99.5% as pharmaceutical companies prioritize enhanced efficacy and safety in finished dosage forms.
Application Tablet - tablet formulations remain the dominant application for pregabalin api due to patient preference and ease of administration in chronic therapies.
Capsule - capsule applications are gaining traction as manufacturers diversify dosage forms to cater to varied patient needs and regulatory requirements.
Oral Liquid - oral liquid formulations are being developed to address pediatric and geriatric patient segments requiring flexible dosing options.
Region North America - north america is seeing steady growth in pregabalin api demand driven by generic drug approvals and robust pharmaceutical infrastructure.
EMEA - emea region is focusing on compliance with evolving regulatory frameworks, influencing the adoption of higher-purity pregabalin api.
APAC - apac is emerging as a key production hub for pregabalin api, supported by cost-effective manufacturing and expanding export opportunities.
LATAM - latam is witnessing gradual market expansion as local pharmaceutical companies increase adoption of pregabalin api in generic formulations.
1 Pregabalin API Market Overview
1.1 Product Definition
1.2 Pregabalin API by Type
1.2.1 Global Pregabalin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Pregabalin API by Application
1.3.1 Global Pregabalin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Oral Liquid
1.4 Global Market Growth Prospects
1.4.1 Global Pregabalin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pregabalin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pregabalin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pregabalin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pregabalin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Pregabalin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pregabalin API, Industry Ranking, 2023 VS 2024
2.4 Global Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pregabalin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pregabalin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pregabalin API, Product Offered and Application
2.8 Global Key Manufacturers of Pregabalin API, Date of Enter into This Industry
2.9 Pregabalin API Market Competitive Situation and Trends
2.9.1 Pregabalin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pregabalin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pregabalin API Production by Region
3.1 Global Pregabalin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pregabalin API Production Value by Region (2020-2031)
3.2.1 Global Pregabalin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pregabalin API by Region (2026-2031)
3.3 Global Pregabalin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pregabalin API Production Volume by Region (2020-2031)
3.4.1 Global Pregabalin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pregabalin API by Region (2026-2031)
3.5 Global Pregabalin API Market Price Analysis by Region (2020-2025)
3.6 Global Pregabalin API Production and Value, Year-over-Year Growth
3.6.1 North America Pregabalin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pregabalin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pregabalin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Pregabalin API Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea Pregabalin API Production Value Estimates and Forecasts (2020-2031)
4 Pregabalin API Consumption by Region
4.1 Global Pregabalin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pregabalin API Consumption by Region (2020-2031)
4.2.1 Global Pregabalin API Consumption by Region (2020-2025)
4.2.2 Global Pregabalin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pregabalin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pregabalin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pregabalin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pregabalin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pregabalin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pregabalin API Production by Type (2020-2031)
5.1.1 Global Pregabalin API Production by Type (2020-2025)
5.1.2 Global Pregabalin API Production by Type (2026-2031)
5.1.3 Global Pregabalin API Production Market Share by Type (2020-2031)
5.2 Global Pregabalin API Production Value by Type (2020-2031)
5.2.1 Global Pregabalin API Production Value by Type (2020-2025)
5.2.2 Global Pregabalin API Production Value by Type (2026-2031)
5.2.3 Global Pregabalin API Production Value Market Share by Type (2020-2031)
5.3 Global Pregabalin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pregabalin API Production by Application (2020-2031)
6.1.1 Global Pregabalin API Production by Application (2020-2025)
6.1.2 Global Pregabalin API Production by Application (2026-2031)
6.1.3 Global Pregabalin API Production Market Share by Application (2020-2031)
6.2 Global Pregabalin API Production Value by Application (2020-2031)
6.2.1 Global Pregabalin API Production Value by Application (2020-2025)
6.2.2 Global Pregabalin API Production Value by Application (2026-2031)
6.2.3 Global Pregabalin API Production Value Market Share by Application (2020-2031)
6.3 Global Pregabalin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 SUANFARMA
7.1.1 SUANFARMA Pregabalin API Company Information
7.1.2 SUANFARMA Pregabalin API Product Portfolio
7.1.3 SUANFARMA Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 SUANFARMA Main Business and Markets Served
7.1.5 SUANFARMA Recent Developments/Updates
7.2 VASUDHA PHARMA
7.2.1 VASUDHA PHARMA Pregabalin API Company Information
7.2.2 VASUDHA PHARMA Pregabalin API Product Portfolio
7.2.3 VASUDHA PHARMA Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 VASUDHA PHARMA Main Business and Markets Served
7.2.5 VASUDHA PHARMA Recent Developments/Updates
7.3 Atom Pharma
7.3.1 Atom Pharma Pregabalin API Company Information
7.3.2 Atom Pharma Pregabalin API Product Portfolio
7.3.3 Atom Pharma Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Atom Pharma Main Business and Markets Served
7.3.5 Atom Pharma Recent Developments/Updates
7.4 Sienna Biotec
7.4.1 Sienna Biotec Pregabalin API Company Information
7.4.2 Sienna Biotec Pregabalin API Product Portfolio
7.4.3 Sienna Biotec Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Sienna Biotec Main Business and Markets Served
7.4.5 Sienna Biotec Recent Developments/Updates
7.5 Kopran
7.5.1 Kopran Pregabalin API Company Information
7.5.2 Kopran Pregabalin API Product Portfolio
7.5.3 Kopran Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Kopran Main Business and Markets Served
7.5.5 Kopran Recent Developments/Updates
7.6 Teva
7.6.1 Teva Pregabalin API Company Information
7.6.2 Teva Pregabalin API Product Portfolio
7.6.3 Teva Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Teva Main Business and Markets Served
7.6.5 Teva Recent Developments/Updates
7.7 Afton Pharma
7.7.1 Afton Pharma Pregabalin API Company Information
7.7.2 Afton Pharma Pregabalin API Product Portfolio
7.7.3 Afton Pharma Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Afton Pharma Main Business and Markets Served
7.7.5 Afton Pharma Recent Developments/Updates
7.8 Cadila
7.8.1 Cadila Pregabalin API Company Information
7.8.2 Cadila Pregabalin API Product Portfolio
7.8.3 Cadila Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Cadila Main Business and Markets Served
7.8.5 Cadila Recent Developments/Updates
7.9 Sunshine Pharmaceutical
7.9.1 Sunshine Pharmaceutical Pregabalin API Company Information
7.9.2 Sunshine Pharmaceutical Pregabalin API Product Portfolio
7.9.3 Sunshine Pharmaceutical Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Sunshine Pharmaceutical Main Business and Markets Served
7.9.5 Sunshine Pharmaceutical Recent Developments/Updates
7.10 Hanmi Fine Chemical
7.10.1 Hanmi Fine Chemical Pregabalin API Company Information
7.10.2 Hanmi Fine Chemical Pregabalin API Product Portfolio
7.10.3 Hanmi Fine Chemical Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hanmi Fine Chemical Main Business and Markets Served
7.10.5 Hanmi Fine Chemical Recent Developments/Updates
7.11 Rivocean Jiangsu Pharmaceutical
7.11.1 Rivocean Jiangsu Pharmaceutical Pregabalin API Company Information
7.11.2 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolio
7.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Rivocean Jiangsu Pharmaceutical Main Business and Markets Served
7.11.5 Rivocean Jiangsu Pharmaceutical Recent Developments/Updates
7.12 Hubei Vanz Pharm
7.12.1 Hubei Vanz Pharm Pregabalin API Company Information
7.12.2 Hubei Vanz Pharm Pregabalin API Product Portfolio
7.12.3 Hubei Vanz Pharm Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Hubei Vanz Pharm Main Business and Markets Served
7.12.5 Hubei Vanz Pharm Recent Developments/Updates
7.13 Menovo
7.13.1 Menovo Pregabalin API Company Information
7.13.2 Menovo Pregabalin API Product Portfolio
7.13.3 Menovo Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Menovo Main Business and Markets Served
7.13.5 Menovo Recent Developments/Updates
7.14 Saintsun
7.14.1 Saintsun Pregabalin API Company Information
7.14.2 Saintsun Pregabalin API Product Portfolio
7.14.3 Saintsun Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Saintsun Main Business and Markets Served
7.14.5 Saintsun Recent Developments/Updates
7.15 SyncoZymes
7.15.1 SyncoZymes Pregabalin API Company Information
7.15.2 SyncoZymes Pregabalin API Product Portfolio
7.15.3 SyncoZymes Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 SyncoZymes Main Business and Markets Served
7.15.5 SyncoZymes Recent Developments/Updates
7.16 Taian Aidi Biotechnology
7.16.1 Taian Aidi Biotechnology Pregabalin API Company Information
7.16.2 Taian Aidi Biotechnology Pregabalin API Product Portfolio
7.16.3 Taian Aidi Biotechnology Pregabalin API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Taian Aidi Biotechnology Main Business and Markets Served
7.16.5 Taian Aidi Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pregabalin API Industry Chain Analysis
8.2 Pregabalin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pregabalin API Production Mode & Process Analysis
8.4 Pregabalin API Sales and Marketing
8.4.1 Pregabalin API Sales Channels
8.4.2 Pregabalin API Distributors
8.5 Pregabalin API Customer Analysis
9 Pregabalin API Market Dynamics
9.1 Pregabalin API Industry Trends
9.2 Pregabalin API Market Drivers
9.3 Pregabalin API Market Challenges
9.4 Pregabalin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pregabalin API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Pregabalin API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Pregabalin API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Pregabalin API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Pregabalin API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Pregabalin API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Pregabalin API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Pregabalin API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pregabalin API as of 2024)
 Table 10. Global Market Pregabalin API Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Pregabalin API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Pregabalin API, Product Offered and Application
 Table 13. Global Key Manufacturers of Pregabalin API, Date of Enter into This Industry
 Table 14. Global Pregabalin API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pregabalin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Pregabalin API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Pregabalin API Production Value Market Share by Region (2020-2025)
 Table 19. Global Pregabalin API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Pregabalin API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Pregabalin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Pregabalin API Production (Tons) by Region (2020-2025)
 Table 23. Global Pregabalin API Production Market Share by Region (2020-2025)
 Table 24. Global Pregabalin API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Pregabalin API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Pregabalin API Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Pregabalin API Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Pregabalin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Pregabalin API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Pregabalin API Consumption Market Share by Region (2020-2025)
 Table 31. Global Pregabalin API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Pregabalin API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Pregabalin API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Pregabalin API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Pregabalin API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Pregabalin API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Pregabalin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Pregabalin API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Pregabalin API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Pregabalin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Pregabalin API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Pregabalin API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Pregabalin API Production (Tons) by Type (2020-2025)
 Table 46. Global Pregabalin API Production (Tons) by Type (2026-2031)
 Table 47. Global Pregabalin API Production Market Share by Type (2020-2025)
 Table 48. Global Pregabalin API Production Market Share by Type (2026-2031)
 Table 49. Global Pregabalin API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Pregabalin API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Pregabalin API Production Value Market Share by Type (2020-2025)
 Table 52. Global Pregabalin API Production Value Market Share by Type (2026-2031)
 Table 53. Global Pregabalin API Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Pregabalin API Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Pregabalin API Production (Tons) by Application (2020-2025)
 Table 56. Global Pregabalin API Production (Tons) by Application (2026-2031)
 Table 57. Global Pregabalin API Production Market Share by Application (2020-2025)
 Table 58. Global Pregabalin API Production Market Share by Application (2026-2031)
 Table 59. Global Pregabalin API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Pregabalin API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Pregabalin API Production Value Market Share by Application (2020-2025)
 Table 62. Global Pregabalin API Production Value Market Share by Application (2026-2031)
 Table 63. Global Pregabalin API Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Pregabalin API Price (US$/Ton) by Application (2026-2031)
 Table 65. SUANFARMA Pregabalin API Company Information
 Table 66. SUANFARMA Pregabalin API Specification and Application
 Table 67. SUANFARMA Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. SUANFARMA Main Business and Markets Served
 Table 69. SUANFARMA Recent Developments/Updates
 Table 70. VASUDHA PHARMA Pregabalin API Company Information
 Table 71. VASUDHA PHARMA Pregabalin API Specification and Application
 Table 72. VASUDHA PHARMA Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. VASUDHA PHARMA Main Business and Markets Served
 Table 74. VASUDHA PHARMA Recent Developments/Updates
 Table 75. Atom Pharma Pregabalin API Company Information
 Table 76. Atom Pharma Pregabalin API Specification and Application
 Table 77. Atom Pharma Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Atom Pharma Main Business and Markets Served
 Table 79. Atom Pharma Recent Developments/Updates
 Table 80. Sienna Biotec Pregabalin API Company Information
 Table 81. Sienna Biotec Pregabalin API Specification and Application
 Table 82. Sienna Biotec Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Sienna Biotec Main Business and Markets Served
 Table 84. Sienna Biotec Recent Developments/Updates
 Table 85. Kopran Pregabalin API Company Information
 Table 86. Kopran Pregabalin API Specification and Application
 Table 87. Kopran Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Kopran Main Business and Markets Served
 Table 89. Kopran Recent Developments/Updates
 Table 90. Teva Pregabalin API Company Information
 Table 91. Teva Pregabalin API Specification and Application
 Table 92. Teva Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Teva Main Business and Markets Served
 Table 94. Teva Recent Developments/Updates
 Table 95. Afton Pharma Pregabalin API Company Information
 Table 96. Afton Pharma Pregabalin API Specification and Application
 Table 97. Afton Pharma Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Afton Pharma Main Business and Markets Served
 Table 99. Afton Pharma Recent Developments/Updates
 Table 100. Cadila Pregabalin API Company Information
 Table 101. Cadila Pregabalin API Specification and Application
 Table 102. Cadila Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Cadila Main Business and Markets Served
 Table 104. Cadila Recent Developments/Updates
 Table 105. Sunshine Pharmaceutical Pregabalin API Company Information
 Table 106. Sunshine Pharmaceutical Pregabalin API Specification and Application
 Table 107. Sunshine Pharmaceutical Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Sunshine Pharmaceutical Main Business and Markets Served
 Table 109. Sunshine Pharmaceutical Recent Developments/Updates
 Table 110. Hanmi Fine Chemical Pregabalin API Company Information
 Table 111. Hanmi Fine Chemical Pregabalin API Specification and Application
 Table 112. Hanmi Fine Chemical Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Hanmi Fine Chemical Main Business and Markets Served
 Table 114. Hanmi Fine Chemical Recent Developments/Updates
 Table 115. Rivocean Jiangsu Pharmaceutical Pregabalin API Company Information
 Table 116. Rivocean Jiangsu Pharmaceutical Pregabalin API Specification and Application
 Table 117. Rivocean Jiangsu Pharmaceutical Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Rivocean Jiangsu Pharmaceutical Main Business and Markets Served
 Table 119. Rivocean Jiangsu Pharmaceutical Recent Developments/Updates
 Table 120. Hubei Vanz Pharm Pregabalin API Company Information
 Table 121. Hubei Vanz Pharm Pregabalin API Specification and Application
 Table 122. Hubei Vanz Pharm Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Hubei Vanz Pharm Main Business and Markets Served
 Table 124. Hubei Vanz Pharm Recent Developments/Updates
 Table 125. Menovo Pregabalin API Company Information
 Table 126. Menovo Pregabalin API Specification and Application
 Table 127. Menovo Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Menovo Main Business and Markets Served
 Table 129. Menovo Recent Developments/Updates
 Table 130. Saintsun Pregabalin API Company Information
 Table 131. Saintsun Pregabalin API Specification and Application
 Table 132. Saintsun Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Saintsun Main Business and Markets Served
 Table 134. Saintsun Recent Developments/Updates
 Table 135. SyncoZymes Pregabalin API Company Information
 Table 136. SyncoZymes Pregabalin API Specification and Application
 Table 137. SyncoZymes Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. SyncoZymes Main Business and Markets Served
 Table 139. SyncoZymes Recent Developments/Updates
 Table 140. Taian Aidi Biotechnology Pregabalin API Company Information
 Table 141. Taian Aidi Biotechnology Pregabalin API Specification and Application
 Table 142. Taian Aidi Biotechnology Pregabalin API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. Taian Aidi Biotechnology Main Business and Markets Served
 Table 144. Taian Aidi Biotechnology Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Pregabalin API Distributors List
 Table 148. Pregabalin API Customers List
 Table 149. Pregabalin API Market Trends
 Table 150. Pregabalin API Market Drivers
 Table 151. Pregabalin API Market Challenges
 Table 152. Pregabalin API Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pregabalin API
 Figure 2. Global Pregabalin API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Pregabalin API Market Share by Type: 2024 VS 2031
 Figure 4. Purity ≥99% Product Picture
 Figure 5. Purity ≥99.5% Product Picture
 Figure 6. Global Pregabalin API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Pregabalin API Market Share by Application: 2024 VS 2031
 Figure 8. Tablet
 Figure 9. Capsule
 Figure 10. Oral Liquid
 Figure 11. Global Pregabalin API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pregabalin API Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Pregabalin API Production Capacity (Tons) & (2020-2031)
 Figure 14. Global Pregabalin API Production (Tons) & (2020-2031)
 Figure 15. Global Pregabalin API Average Price (US$/Ton) & (2020-2031)
 Figure 16. Pregabalin API Report Years Considered
 Figure 17. Pregabalin API Production Share by Manufacturers in 2024
 Figure 18. Global Pregabalin API Production Value Share by Manufacturers (2024)
 Figure 19. Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Pregabalin API Revenue in 2024
 Figure 21. Global Pregabalin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Pregabalin API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Pregabalin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 24. Global Pregabalin API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Pregabalin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Pregabalin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Pregabalin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. India Pregabalin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. South Korea Pregabalin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Pregabalin API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 31. Global Pregabalin API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. North America Pregabalin API Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Canada Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Europe Pregabalin API Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. France Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. U.K. Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Italy Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Russia Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Asia Pacific Pregabalin API Consumption Market Share by Region (2020-2031)
 Figure 45. China Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Japan Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. South Korea Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. China Taiwan Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Southeast Asia Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. India Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Latin America, Middle East & Africa Pregabalin API Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Brazil Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Turkey Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. GCC Countries Pregabalin API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Global Production Market Share of Pregabalin API by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Pregabalin API by Type (2020-2031)
 Figure 59. Global Pregabalin API Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Production Market Share of Pregabalin API by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Pregabalin API by Application (2020-2031)
 Figure 62. Global Pregabalin API Price (US$/Ton) by Application (2020-2031)
 Figure 63. Pregabalin API Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure